Insights

Chrysos Corporation share price plummets 40% on ASX debut

The ASX newbie offers a fresh way to analyse gold assays.
The post Chrysos Corporation share price plummets 40% on ASX debut appeared first on The Motley Fool Australia. –

After much anticipation, Chrysos Corporation Limited (ASX: C79) shares hit the ASX this morning, tumbling to trade 34.9% lower than the company’s initial public offering (IPO) asking price.

The mining technology company provides PhotonAssay, a gold assay solution. The tech is said to deliver faster, safer, and more accurate gold analysis.

At the time of writing, the Chrysos share price is $4.23, down from its IPO asking price of $6.50. However, earlier today it plunged to $3.90, representing a 40% tumble.

Let’s take a closer look at the mining technology company’s journey to the ASX and what it’s planning to do moving forward.

Chrysos share price sinks on ASX float

All eyes are on the Chrysos share price as the company hits the ASX following its $183.5 million IPO.

Some 28.2 million Chrysos shares were offered for $6.50 apiece under the company’s prospectus.

Funds raised through its IPO will help the company manufacture and deploy more PhotoAssay units. PhotonAssay works by exciting gold atoms with X-rays.

The company makes its money by leasing PhotonAssay units to customers under long-term contracts. Those customers pay the company per assay they process using the technology.

Chrysos already has contracts signed for 33 units, reflecting a total contract value of $448 million.

It also has sales commitments extending to 2024, a 5.4% market penetration, and an addressable market of 610 PhotoAssay units.

Its customers include two of the world’s biggest producing gold miners and three of the world’s largest testing, inspection, and certification companies.

The CSIRO – which originally conceived the technology – remains a major Chrysos shareholder.

Commenting before the company’s float, Chrysos CEO and managing director Dirk Treasure said:

PhotonAssay represents the first major advancement in gold assaying in centuries and aims to displace the existing fire assay method. It offers a unique solution to a range of operational, economic and ESG challenges currently facing mining and exploration companies.

We have already made significant headway in the acceptance of PhotonAssay within the gold sector … yet there is so much potential ahead of us for growth within our addressable market, and further expansion into the analysis of other elements such as silver and copper.

The company expected to list with a market capitalisation of around $637 million and 98 million outstanding shares. However, at its current share price, Chrysos has a valuation of approximately $401 million.

The post Chrysos Corporation share price plummets 40% on ASX debut appeared first on The Motley Fool Australia.

Should you invest $1,000 in Chrysos right now?

Before you consider Chrysos, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Chrysos wasn’t one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of January 13th 2022

More reading

Are you investing with the odds in your favour?
PolyNovo share price jumps despite the market selloff amid heavy insider buying
Grounded! Why the Qantas share price is tanking 4% today
Why is the Pilbara Minerals share price sinking 9% today?
Atomos share price plunges 42% lower on ‘slower than expected sales’

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

  • This field is for validation purposes and should be left unchanged.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US & HK* Trades. Click Here!